Previews
Key features
- ML-Based Subtype Classification — Enhances subtype coverage by 7%, correctly identifying DUX4-rearrangements and ETV6::RUNX1-like subtypes to prevent unnecessary or escalated treatments.
- Consolidated Reporting — Simplifies laboratory workflows by combining gene expression-based subtyping and gene fusion identification into one comprehensive clinical report.
- Multi-Caller Fusion Detection — Utilizes up to three different gene fusion callers for maximum robustness, presenting results in a tiered format for clinical clarity.
- Cost-Effective Diagnostic Path — Offers significant savings by potentially replacing multiple FISH tests with a single RNA-seq analysis.
- Future-Proof WTS Architecture — Leverages Whole Transcriptome Sequencing (WTS), allowing for new clinical annotations and updates via software rather than changing physical lab workflows.